NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 3429.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 30-Jun-2014
Neuron
Potential drug target for PTSD prevention
Scientists have identified a drug that appears to make memories of fearsome events less durable in mice. The finding may accelerate the development of treatments for preventing PTSD. The drug, called osanetant, targets a distinct group of brain cells in a region of the brain that controls the formation and consolidation of fear memories.
National Institute of Mental Health, Burroughs Wellcome, Howard Hughes Medical Institute, NIH/National Institute of Neurological Disorders and Stroke

Contact: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory Health Sciences

Public Release: 30-Jun-2014
JAMA Internal Medicine
Insulin, other drugs may do more harm than good for some type 2 diabetes patients
Many patients with type 2 diabetes may be overtreated with insulin and other glucose-lowering drugs.
National Institutes of Health, US Department of Veterans Affairs, Quality Enhancement Research Initiative

Contact: Beata Mostafavi
bmostafa@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 30-Jun-2014
JAMA Internal Medicine
BMC study: Treat patients with addiction during, after hospitalization
The results of a new study demonstrate that starting hospitalized patients who have an opioid addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment program can greatly reduce whether they relapse after they are discharged.
NIH/National Institute on Drug Abuse

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center

Public Release: 30-Jun-2014
Journal of Clinical Oncology
HIV-positive people with early-stage cancer up to 4 times more likely to go untreated for cancer
HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute published online ahead of print in the Journal of Clinical Oncology.
NIH/National Cancer Institute

Contact: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Scientists engineer nanoparticles to prevent bone cancer, strengthen bones
A research collaboration between Brigham and Women's Hospital and Dana-Farber Cancer Institute has utilized nanomedicine technologies to develop a drug-delivery system that can precisely target and attack cancer cells in the bone, as well as increase bone strength and volume to prevent bone cancer progression.
National Institutes of Health

Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-6383
Brigham and Women's Hospital

Public Release: 30-Jun-2014
Proceedings of the National Academy of Sciences
Clot-building nanoparticles raise survival rate following blast trauma
In preclinical tests led by a Case Western Reserve University researcher, artificial platelets, called 'hemostatic nanoparticles,' when injected after blast trauma increased survival rates to 95 percent from 60 percent, and showed no signs of interfering with healing or causing other complications weeks afterward.
US Department of Defense, National Institutes of Health

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University

Public Release: 30-Jun-2014
Nature Communications
It may take guts to cure diabetes
By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin. The new research was reported today in the online issue of the journal Nature Communications.
National Institutes of Health, Manpei Suzuki Diabetes Foundation, Swedish Society for Medical Research

Contact: Karin Eskenazi
ket2116@cumc.columbia.edu
212-342-0508
Columbia University Medical Center

Public Release: 29-Jun-2014
Nature Neuroscience
Noninvasive brain control
MIT engineers have now developed the first light-sensitive molecule that enables neurons to be silenced noninvasively, using a light source outside the skull.
Defense Advanced Research Projects Agency, Human Frontiers Science Program, IET A. F. Harvey Prize, MIT McGovern Institute, New York Stem Cell Foundation, National Institutes of Health, National Science Foundation, Wallace H. Coulter Foundation, others

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 29-Jun-2014
Nature Medicine
Massachusetts General-developed protocol could greatly extend preservation of donor livers
A system developed by investigators at the Massachusetts General Hospital Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.
National Institutes of Health, Shriners Hospitals for Children

Contact: Cassandra Aviles
cmaviles@partners.org
617-724-6433
Massachusetts General Hospital

Public Release: 29-Jun-2014
Nature Chemical Biology
Marine bacteria are natural source of chemical fire retardants
Researchers at the University of California, San Diego School of Medicine have discovered a widely distributed group of marine bacteria that produce compounds nearly identical to toxic man-made fire retardants.
National Science Foundation, NIH/National Institute of Environmental Health Sciences

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 29-Jun-2014
Nature Neuroscience
Watching individual neurons respond to magnetic therapy
Duke researchers have developed a method to record an individual neuron's response to transcranial magnetic stimulation therapy. The advance will help researchers understand the underlying physiological effects of TMS -- a procedure used to treat psychiatric disorders -- and optimize its use as a therapeutic treatment.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Ken Kingery
ken.kingery@duke.edu
919-660-8414
Duke University

Public Release: 29-Jun-2014
Nature Genetics
A single gene separates aggressive and non-aggressive lymphatic system cancer
For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn't require extensive therapy.
NIH/National Cancer Institute

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 27-Jun-2014
PLOS ONE
Herpes virus infection drives HIV infection among non-injecting drug users in New York
The study conducted among drug users entering the Mount Sinai Beth Israel drug treatment programs in NYC found that HIV infection among non-injecting drug users doubled over the last two decades.
National Institutes of Health

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 27-Jun-2014
Journal of Experimental Medicine
Potential Alzheimer's drug prevents abnormal blood clots in the brain
The brains of Alzheimer's mice treated with the compound RU-505 showed less inflammation and improved blood flow than those of untreated mice. The treated mice also performed better on memory tests.
National Institutes of Health, Thome Memorial Medical Foundation, Alzheimer's Drug Discovery Foundation, Woodbourne Foundation, and others

Contact: Zach Veilleux
zveilleux@rockefeller.edu
212-327-8982
Rockefeller University

Public Release: 27-Jun-2014
Nature
Research gives unprecedented 3-D view of important brain receptor
Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain -- a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.
Bernard and Jennifer Lacroute, National Institutes of Health

Contact: Todd Murphy
murphyt@ohsu.edu
503-494-8231
Oregon Health & Science University

Public Release: 27-Jun-2014
Cell Reports
Some aggressive cancers may respond to anti-inflammatory drugs
New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.
National Institutes of Health, US Department of Defense

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Public Release: 27-Jun-2014
Science
USAMRIID research sheds light on how deadly lassa virus infects cells
An international team of scientists has discovered that the Lassa virus, endemic to West Africa, uses an unexpected two-step process to enter cells. The results, published in today's edition of Science, suggest that the mechanism by which Lassa virus causes infection is more complicated than previously known, and could lead to new approaches for preventing the disease. Collaborators included USAMRIID, the Netherlands Cancer Institute, the University of Kiel in Germany, and Harvard Medical School.
Defense Threat Reduction Agency, European Research Council, National Institutes of Health

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 27-Jun-2014
Nature Neuroscience
New form of brain signaling affects addiction-related behavior
University of Iowa researchers have discovered a new form of neurotransmission that influences the long-lasting memory created by addictive drugs, like cocaine and opioids, and the subsequent craving for these drugs of abuse. Loss of this type of neurotransmission creates changes in brains cells that resemble the changes caused by drug addiction. The findings suggest that targeting this type of neurotransmission might lead to new therapies for treating drug addiction.
National Institutes of Health, NARSAD, Department of Veterans Affairs

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-356-7124
University of Iowa Health Care

Public Release: 27-Jun-2014
Journal of Lipid Research
Sex hormone levels at midlife linked to heart disease risk in women
As hormone levels change during the transition to menopause, the quality of a woman's cholesterol carriers degrades, leaving her at greater risk for heart disease, researchers at the University of Pittsburgh Graduate School of Public Health discovered. The first-of-its-kind evaluation, supported by the National Institutes of Health, was done using an advanced method to characterize cholesterol carriers in the blood and is published in the July issue of the Journal of Lipid Research.
National Institutes of Health

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 27-Jun-2014
American Journal of Managed Care
Prevention incentives
A private South African health plan increased patient use of preventive care with an incentive program that rewards healthy behavior using discounts on retail goods and travel.
National Institutes of Health Common Fund

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 26-Jun-2014
Science
Sequencing electric eel genome unlocks shocking secrets
For the first time, the genome of the electric eel has been sequenced. This discovery has revealed the secret of how fishes with electric organs have evolved six times in the history of life to produce electricity outside of their bodies.
National Science Foundation, National Institutes of Health

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 26-Jun-2014
Clinical Cancer Research
Researchers home in on way to predict aggressiveness of oral cancer
Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers at Washington University School of Medicine in St. Louis.
National Institutes of Health

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Public Release: 26-Jun-2014
Science
New infections cause dormant viruses to reactivate
The famous slogan is 'A diamond is forever,' but that phrase might be better suited to herpes: Unlike most viruses, which succumb to the immune system's attack, herpes remains in the body forever, lying in wait, sometimes reactivating years later.
National Institutes of Health

Contact: April Frawley
afrawley@ufl.edu
352-273-5817
University of Florida

Public Release: 26-Jun-2014
Journal of Neuroscience
Blocking key enzyme minimizes stroke injury, UT Southwestern research finds
A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests.
National Institutes of Health

Contact: Debbie Bolles
debbie.bolles@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 26-Jun-2014
Cancer Cell
Diabolical duo: Known breast cancer gene needs a partner to initiate and spread tumors
A team led by Princeton University researchers has found that a gene known as Metadherin promotes the survival of tumor-initiating cells via the interaction with a second molecule called SND1. The finding could suggest new treatment strategies.
US Department of Defense, National Institutes of Health, Cancer Institute of New Jersey

Contact: Catherine Zandonella
czandone@princeton.edu
609-258-0541
Princeton University

Showing releases 226-250 out of 3429.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.